Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BioNTech

BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.

BioNTech unexpectedly reported a third-quarter profit and better-than-expected sales on Monday, pushing BNTX stock higher.

Investors Business Daily

Pfizer Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid

Pfizer is hiking its Paxlovid price to $1,390 for a five-day course of the Covid pill. But Pfizer stock fell early Thursday.

Investors Business Daily

Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion

Moderna stock and BioNTech stock led a sell-off Monday among Covid vaccine makers after Pfizer slashed its full-year guidance.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

University of Pennsylvania slammed for celebrating Nobel prize of vaccine researcher it once demoted

University once reportedly discouraged Katalin Karikó from pursuing mRNA research that later helped create Covid vaccines

The Independent UK

Novavax Surges After FDA Signs Off On Its Updated Covid Shot, Joining Pfizer, Moderna

The Food and Drug Administration signed off on Novavax's updated Covid booster late Tuesday, and NVAX stock surged just before the close.

Investors Business Daily

The trouble with a Nobel for mRNA COVID vaccines

The mRNA vaccine story during the COVID-19 pandemic placed an extraordinary premium on altruism on the part of scientists

The Hindu

The scientist whose research was key to developing the COVID vaccines was demoted, had her salary cut, and threatened with deportation. Today, she won the Nobel Prize

Katalin Karikó, now a vice-president at BioNTech, saw her research undermined for years before the 2005 breakthrough that led to the COVID-19 vaccine.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Years of research laid the groundwork for speedy COVID-19 shots

The Nobel Prize in Medicine has been awarded to two scientists whose work led to mRNA vaccines against COVID-19

The Independent UK

Katalin Kariko, scientific maverick who paved way for mRNA vaccines

Katalin Kariko’s pioneering work -- which paved the way for the Pfizer/BioNTech and Moderna Covid-19 vaccines -- has won her the Nobel Prize in Medicine.

The Hindu

Covid Vaccine Rally Dashed As Pfizer, Moderna Give Back Gains On Eris' Advance

Pfizer stock and Moderna stock dipped Friday — giving back some of their late Thursday gains on an upswing related to their updated Covid shots.

Investors Business Daily

BioNTech Trims Expenses As Plummeting Covid Vaccine Sales Still Lag Expectations

BioNTech said Monday it's trimming drug development costs amid plummeting Covid vaccine sales. In response, BNTX stock tumbled.

Investors Business Daily

Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.

The biggest names in Covid are updating their vaccines for a fall campaign, but that might not bolster Pfizer stock and Moderna stock.

Investors Business Daily

The Most Objective Evidence Shows No Indication That Covid Vaccines Save More Lives Than They Take

Medical journals describe all-cause mortality in randomized controlled trials (RCTs)

Zenger

Up to 10,000 Britons could take part in cancer vaccine trials

Participants could receive groundbreaking treatment after the Government signed an agreement with a leading pharmaceutical company.

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Zenger

Moderna Stock Rises After FDA Application For Updated Vaccine

Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy

StockNews.com

Moderna (MRNA) vs. BioNTech (BNTX): Which Biotech Stock Should You Be Investing In?

Amidst the biotech industry’s rapid growth and notable advancements, let’s analyze which of the two major players, Moderna (MRNA) and BioNTech (BNTX), is a more favorable investment choice in the current uncertain economic climate. Keep reading to find out.

The Guardian - UK

‘Designing a vaccine that covers all cancers is hard’: biotech pioneer Lindy Durrant

The immunologist who runs Scancell is trialling novel treatments to attack tumours, as well as needle-free Covid jabs

Inverse

mRNA Vaccines Could Revolutionize Cancer Treatment

Here’s a look at the status of mRNA technology's application in cancer and when it might reach patients.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

BioNTech Surges On This Promising Update In Its Bid To Take On Bristol Myers In Lung Cancer Treatment

BioNTech said Friday almost a third of patients with a hard-to-treat form of lung cancer responded to its treatment — and BNTX stock popped.

The Independent UK

Ukraine, Sudan conflicts fuel alarming surge in tuberculosis

Top U.N. officials and health industry leaders are trying to tackle an alarming surge in tuberculosis, which is now killing more people worldwide than COVID-19 or AIDS

Investors Business Daily

BioNTech Trounces First-Quarter Profit Views, But Covid Declines Will Continue

BioNTech crushed Wall Street's profit views Monday, but shares dipped at the close amid expectations for more drops in Covid vaccine sales.

Asharq Al-Awsat

Pfizer, BioNTech Propose EU Pays Half for Each Cancelled COVID Dose

Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay half price, or about 10 euros ($11), for each of about 70 million cancelled doses, the Financial Times reported on Sunday. The revised contract would allow…

The Independent UK

‘Groundbreaking’ cancer and heart disease vaccine ‘could save millions of lives’

Experts hope new vaccines will be ready by end of decade

The Guardian - UK

‘A silver lining’: how Covid ushered in a vaccines golden era

Pandemic accelerated advances in vaccine technology, opening up possibilities for combating array of diseases

Investors Business Daily

BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion

BioNTech said Monday it expects roughly $5.4 billion in sales of its Covid shot this year, missing views and leading BNTX stock to tumble.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Food and Drug Administration

151 stories

University of Pennsylvania

114 stories

the University of Pennsylvania

81 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.